RhumbLine Advisers’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,755
| Closed | -$16.5K | – | 4271 |
|
|
2024
Q2 | $16.5K | Sell |
2,755
-8,189
| -75% | -$49.1K | ﹤0.01% | 3896 |
|
|
2024
Q1 | $98.7K | Buy |
10,944
+258
| +2% | +$2.33K | ﹤0.01% | 3451 |
|
|
2023
Q4 | $101K | Hold |
10,686
| – | – | ﹤0.01% | 3442 |
|
|
2023
Q3 | $127K | Sell |
10,686
-669
| -6% | -$7.96K | ﹤0.01% | 3378 |
|
|
2023
Q2 | $278K | Buy |
11,355
+3,154
| +38% | +$77.3K | ﹤0.01% | 3060 |
|
|
2023
Q1 | $257K | Buy |
8,201
+228
| +3% | +$7.15K | ﹤0.01% | 2661 |
|
|
2022
Q4 | $561K | Buy |
7,973
+87
| +1% | +$6.12K | ﹤0.01% | 2412 |
|
|
2022
Q3 | $679K | Buy |
7,886
+1,249
| +19% | +$108K | ﹤0.01% | 2351 |
|
|
2022
Q2 | $549K | Buy |
6,637
+1,985
| +43% | +$164K | ﹤0.01% | 2457 |
|
|
2022
Q1 | $773K | Buy |
4,652
+605
| +15% | +$101K | ﹤0.01% | 2233 |
|
|
2021
Q4 | $677K | Buy |
4,047
+54
| +1% | +$9.03K | ﹤0.01% | 2383 |
|
|
2021
Q3 | $345K | Buy |
3,993
+108
| +3% | +$9.33K | ﹤0.01% | 2707 |
|
|
2021
Q2 | $211K | Sell |
3,885
-214
| -5% | -$11.6K | ﹤0.01% | 2913 |
|
|
2021
Q1 | $244K | Sell |
4,099
-199
| -5% | -$11.8K | ﹤0.01% | 2774 |
|
|
2020
Q4 | $224K | Buy |
4,298
+723
| +20% | +$37.7K | ﹤0.01% | 2794 |
|
|
2020
Q3 | $173K | Sell |
3,575
-439
| -11% | -$21.2K | ﹤0.01% | 2730 |
|
|
2020
Q2 | $208K | Buy |
4,014
+859
| +27% | +$44.5K | ﹤0.01% | 2749 |
|
|
2020
Q1 | $138K | Buy |
3,155
+980
| +45% | +$42.9K | ﹤0.01% | 2703 |
|
|
2019
Q4 | $87K | Sell |
2,175
-18
| -0.8% | -$720 | ﹤0.01% | 2884 |
|
|
2019
Q3 | $72K | Buy |
2,193
+186
| +9% | +$6.11K | ﹤0.01% | 2910 |
|
|
2019
Q2 | $155K | Buy |
2,007
+626
| +45% | +$48.3K | ﹤0.01% | 2855 |
|
|
2019
Q1 | $245K | Buy |
+1,381
| New | +$245K | ﹤0.01% | 2654 |
|